Edition:
United States

People: Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

5.30USD
1:37pm EDT
Change (% chg)

$0.45 (+9.28%)
Prev Close
$4.85
Open
$5.20
Day's High
$5.30
Day's Low
$5.10
Volume
105,497
Avg. Vol
169,882
52-wk High
$30.35
52-wk Low
$4.62

Crew, Timothy 

Mr. Timothy C. Crew is Chief Executive Officer, Director of the Company. He has more than 25 years of experience in the generic and branded pharmaceutical industries, most recently serving as Chief Executive Officer of Cipla North America, a global pharmaceutical company based in Mumbai, India, from 2013 to 2017. Previously, he worked for eight years at Teva Pharmaceuticals Industries Ltd. (“Teva”), where he served as Senior Vice President and Commercial Operating Officer of the North American Generics division, the world’s largest generic operation with multibillion dollars of annual sales. Before that, he was Teva’s Vice President, Alliances and Business Development. From 2001 to 2004, Mr. Crew was Executive Vice President, North America, for Dr. Reddy’s Laboratories Ltd. Mr. Crew began his pharmaceutical career at Bristol-Myers Squibb, where he held a number of senior management positions in global marketing, managed healthcare, marketing, business development and strategic planning. Prior to his pharmaceutical roles, Mr. Crew served in the United States Army, where he rose to the rank of Captain. Mr. Crew earned a Bachelor of Arts degree in economics from Pomona College and a Masters of Business Administration degree from Columbia Business School.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --